Frontpage Quality & Knowledge Health Technology Assessments (HTA)

Get the newest information about «Health Technology Assessments (HTA)»

How often would you like to receive alerts from fhi.no? (This affects all your alerts)

As soon as new content is published
Daily
Weekly

You will only receive an alert if new information was published since you received one.

The email address you register will only be used to send you these alerts. You can cancel your alerts and delete your email address at any time by following the link in the alerts you receive.
Read more about the privacy policy for fhi.no

You have subscribed to alerts about:

Health Technology Assessments (HTA)

Health Technology Assessments (HTA)

The Norwegian Institute of Public Health contributes to national and international Health Technology Assessments.

Les på norsk

HTA for low and middle-income countries

Article

Supporting implementation of HTA in low-and middle-income countries

The Norwegian Institute of Public Health (NIPH) is partnering with low-and middle-income countries to support local implementation of health technology assessments (HTA).

Updated 14.04.2021

Article

Vaccine communication and digital strategies

Governments worldwide are currently planning the rollout of COVID-19 vaccines. Here are three information leaflets for planners and implementers.

Published 21.12.2020

Article

HTA status in the Balkan region

A WHO workshop on HTA in support of universal health coverage in the Balkan region was held in Ljubljana, Slovenia, in February 2020.

Published 23.11.2020

Reports

Health technology assessment

Autologous stem cell transplantation for multiple sclerosis

We were commissioned to identify and map ongoing and published randomized controlled trials on the effect of autologous stem cell transplantation for the treatment of multiple sclerosis.

Published 02.09.2021

Health technology assessment

Bronchial thermoplasty for the treatment of severe asthma

Patients suffering from severe treatment-resistant asthma currently have few available treatment options. For these patients, bronchial thermoplasty (BT) may be an alternative. We have assessed the cu...

Published 17.08.2021

Health technology assessment

Evaluation of PD-L1 assays in urothelial carcinoma

The Ordering Forum (Bestillerforum for nye metoder) commissioned the Norwegian Institute of Public Health to evaluate commercial PD-L1 tests for use in treatment of urothelial carcinoma.

Published 17.08.2021

Health technology assessment

Hysterectomy for heavy menstrual bleeding

We have conducted a rapid health technology assessment of hysterectomy (surgical removal of the uterus) for heavy menstrual bleeding on behalf of the Commissioning Forum Regional Health Authority.

Published 10.06.2021

Health technology assessment

Ofatumumab for the treatment of relapsing remitting multiple sclerosis

We have conducted a rapid health technology assessment (HTA) of ofatumumab to treat of adults with relapsing remitting multiple sclerosis (RRMS) on behalf of the Commissioning Forum.

Published 19.05.2021

Health technology assessment

Natalizumab subcutaneous for the treatment of relapsing remitting multiple sclerosis

We conducted a rapid HTA of the subcutaneous administration of natalizumab for treatment of adult patients with relapsing remitting multiple sclerosis (RRMS).

Published 19.05.2021

Health technology assessment

Liposuction (lipectomy) for the treatment of fat accumulation caused by chronic lymphoedema

We were commissioned to assess the efficacy, safety and the health economic consequences of liposuction (lipectomy) for the treatment of chronic lymphoedema.

Published 12.05.2021

Health technology assessment

Minimally Invasive Glaucoma Surgery (MIGS) for individuals with glaucoma

Denne metodevurderingen (HTA) oppsummerer og supplerer en kanadisk HTA fra 2019 om effekt og sikkerhet ved minimal-invasiv glaukomkirurgi (MIGS).

Published 22.04.2021

Health technology assessment

Intravenous immunoglobulin treatment in children with PANS/PANDAS conditions

We have investigated the effect and safety of treatment with immunoglobulins in the conditions PANS) and PANDAS.

Published 09.03.2021

Projects

Disinvestment of medical technologies in Specialist Healthcare Services
Safety, clinical effectiveness, diagnostic accuracy and cost effectiveness of blood-based tests for women with suspected pre-eclampsia
Health Technology Assessment of medicines, including rituximab, used for primary progressive multiple sclerosis (PPMS)
Intermittent pneumatic compression to prevent deep vein thrombosis (DVT) in immobile patients with acute stroke
Surgery for carpal tunnel syndrome - Protocol for Health Technology Assessment

See all

Get the newest information about «Health Technology Assessments (HTA)»

You have subscribed to alerts about:

Health Technology Assessments (HTA)

HTA for low and middle-income countries

Supporting implementation of HTA in low-and middle-income countries

Vaccine communication and digital strategies

HTA status in the Balkan region

Reports

Autologous stem cell transplantation for multiple sclerosis

Bronchial thermoplasty for the treatment of severe asthma

Evaluation of PD-L1 assays in urothelial carcinoma

Hysterectomy for heavy menstrual bleeding

Ofatumumab for the treatment of relapsing remitting multiple sclerosis

Natalizumab subcutaneous for the treatment of relapsing remitting multiple sclerosis

Liposuction (lipectomy) for the treatment of fat accumulation caused by chronic lymphoedema

Minimally Invasive Glaucoma Surgery (MIGS) for individuals with glaucoma

Intravenous immunoglobulin treatment in children with PANS/PANDAS conditions

Projects

See also

Systematic reviews

Health service quality measurements

Evidence to Decisions